|
CNI |
Form 5 - Quarterly Listing Statement (Q2 March 31, 2022) |
Quarterly Listing Statement |
18/05/2022 |
 Open Filing (828.37 KB) |
|
CNI |
Certificate of Interim Filings - CFO |
Other |
18/05/2022 |
Open Filing (184.46 KB) |
|
CNI |
Certificate of Interim Filings - CEO |
Other |
18/05/2022 |
Open Filing (186.92 KB) |
|
CNI |
Management's Discussion and Analysis for the Three and Six Months Ended March 31, 2022 and 2021 |
MD&A (Management Discussion and Analysis) |
18/05/2022 |
Open Filing (314.5 KB) |
|
CNI |
Interim Financial Statements for the Three and Six Months Ended March 31, 2022 and 2021 |
Interim Financial Statements |
18/05/2022 |
Open Filing (423.06 KB) |
|
NXU |
22-05-18 Form 13 Amendment to Warrant Terms |
Notice of Amendment of Warrant Terms |
18/05/2022 |
Open Filing (257.68 KB) |
|
BLAB |
Britannia Secures Agreement with RST to Supply UK CBD Market |
Press Release |
18/05/2022 |
Open Filing (42.17 KB) |
|
BLAB |
Britannia Life Sciences Inc. Reports Third Quarter Financial Results and Provides Update on Operations |
Press Release |
18/05/2022 |
Open Filing (63.85 KB) |
|
BLAB |
Britannia Life Sciences Establishes New Subsidiary to Service the Global Mining Sector |
Press Release |
18/05/2022 |
Open Filing (30.99 KB) |
|
BLAB |
Britannia Life Sciences Announces Closing of £5,000,000 Loan Facility |
Press Release |
18/05/2022 |
Open Filing (32.15 KB) |
